CNS Pharmaceuticals Updates on Berubicin Study in GBM
25 Nov 2024 //
ACCESSWIRE
Costly Brain-Cancer Drug No Longer Covered by Medicare
18 Jun 2021 //
WSJ
lomustine - List of nationally authorised medicinal products
05 Oct 2018 //
EMA
Tocagen begins enrolling patients in Toca 5 phase 2/3 trial in South Korea
16 Jan 2017 //
PHARMABIZ
NextSource Biotechnology Gains FDA Approval for New 5 mg Strength of Gleostine
20 Jan 2016 //
PR NEWSWIRE